Invizyne Technologies Inc. (NASDAQ:IZTC) CEO Acquires $22,022.40 in Stock

Invizyne Technologies Inc. (NASDAQ:IZTC) CEO Michael Heltzen acquired 1,984 shares of the stock in a transaction on Friday, November 15th. The stock was bought at an average price of $11.10 per share, with a total value of $22,022.40. Following the transaction, the chief executive officer now directly owns 1,984 shares of the company’s stock, valued at approximately $22,022.40. The trade was a ∞ increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Invizyne Technologies Trading Up 10.6 %

Shares of IZTC opened at $14.50 on Friday. Invizyne Technologies Inc. has a twelve month low of $8.50 and a twelve month high of $14.50.

Invizyne Technologies Company Profile

Invizyne Technologies Inc is a cell-free enzyme-based biomanufacturing technology company. It redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources into highly sought after biochemicals. Invizyne Technologies Inc is based in Monrovia, CA.